WaveMan
WaveMan · Company
OPRX · Optimizerx Corp
> Search tickers & screens ⌘K
LIVE
← All companies

OPRX OptimizeRx (OPRX) Insider Trading, Ownership & Congress Trades

Services · Services-business services, nec · CIK 0001448431
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
54
13F, latest reported quarter

OptimizeRx insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for OptimizeRx Corp in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Stelmakh Edward
Chief Finance & Strat Officer
SELL
2025-12-22 SECtraded 2025-12-19
1,388
$18.8K
-28.8%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Aug 15, 2022.
  • The trade is 1.1% of the 126,830 shares held after it.
  • No other insider sold within 30 days.
  • 54 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Finance & Strat Officer Stelmakh Edward sold about $18.8K of OPRX on Dec 19, 2025; 54 funds added in the latest 13F quarter.
Silvestro Stephen L
Chief Executive Officer
SELL
2025-10-07 SECtraded 2025-10-03
1,620
$30.4K
-50.3%
Context
  • 7 earlier Form 4 trades (code P or S) here by this insider (1 buy, 6 sales), the last on Aug 16, 2022.
  • The trade is 0.9% of the 188,916 shares held after it.
  • No other insider sold within 30 days.
  • 54 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Silvestro Stephen L sold about $30.4K of OPRX on Oct 3, 2025; 54 funds added in the latest 13F quarter.
Spangler Patrick D
Director
SELL
2025-09-11 SECtraded 2025-08-28
11,120
$194.5K
-47.7%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Nov 11, 2021.
  • The trade is 25.1% of the 44,215 shares held after it.
  • No other insider sold within 30 days.
  • 54 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Spangler Patrick D sold about $194.5K of OPRX on Aug 28, 2025, the largest insider sale at the company since 2022; 54 funds added in the latest 13F quarter.
Lang James Paul
Director
BUY
2025-03-19 SECtraded 2025-03-14
321,408
$2.4M
+3.2%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Aug 19, 2022.
  • The trade is 82.5% of the 389,452 shares held after it.
  • No other insider bought within 30 days.
  • 54 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Lang James Paul bought about $2.4M of OPRX on Mar 14, 2025, the largest insider purchase at the company on our record; 54 funds added in the latest 13F quarter.
FEBBO WILLIAM J
CEO
BUY
2024-12-16 SECtraded 2024-12-12
20,000
$100.2K
+73.4%
Context
  • 13 earlier Form 4 trades (code P or S) here by this insider (2 buys, 11 sales), the last on Aug 22, 2022.
  • +35.2% median (+35.2% mean) 90-day return after 2 previous buys.
  • The trade is 3.3% of the 601,253 shares held after it.
  • No other insider bought within 30 days.
  • 54 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO FEBBO WILLIAM J bought about $100.2K of OPRX on Dec 12, 2024, the largest insider purchase at the company since 2022; 54 funds added in the latest 13F quarter.
55 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 50 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
54 funds bought in last quarter
below 62% of Services
Revenue
+18.8% year over year
more than 75% of Services
Margin
4.7% net margin
more than 59% of Services
Buybacks
no share repurchases reported
Short interest
7.5% of the float short (float per yahoo 2026-10-27) · 6.7 days to cover · settled 2026-10-15
more than 72% of Services
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch OPRX

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-53.7%12M
-77%-48%-18%+11%2025-102025-122026-022026-042026-062026-082026-10 2025-12-19 · Stelmakh Edward sold $18.8K
Insider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns OPRX: institutional holders (13F)

13F holdings, latest reported quarter
Whetstone Capital Advisors, LLC
1,508,303 sh
$8.6M
ROYCE & ASSOCIATES LP
1,089,398 sh
$6.2M
VANGUARD CAPITAL MANAGEMENT LLC
699,604 sh
$4.0M
KENNEDY CAPITAL MANAGEMENT LLC
644,150 sh
$3.7M
RICE HALL JAMES & ASSOCIATES, LLC
633,842 sh
$3.6M

Congress trades in OPRX

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

OPRX planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

OPRX mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Jacob Internet Fund
$1.6M position · as of 2026-05-31
3.6%
Jacob Discovery Fund
$462.7K position · as of 2026-05-31
2.9%
NORTH SQUARE KENNEDY MICROCAP FUND
$94.3K position · as of 2026-05-31
0.3%
Royce Quant Small-Cap Quality Value ETF
$65.0K position · as of 2026-06-30
0.2%
Royce Small-Cap Opportunity Fund
$2.9M position · as of 2026-06-30
0.2%
Clearwater Select Equity Fund
$741.7K position · as of 2026-06-30
0.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 54 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
DASHABNBSEETSYFICOXMTRACNZGFLYWMAMAXPHR

OPRX financials

Revenue growth
+18.8%
XBRL, annual
Net margin
4.7%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$98.7M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+4.7%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$18.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.15x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Cash flow to debt
0.97x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Return on equity
+3.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+2.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
+7.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
39.43x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
$165.8M
market value at close 2026-10-26 on 2026-07-30 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
FCF yield
+10.7%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$109.4M$92.1M$71.5M$62.5M
Gross profit$73.6M$59.4M$42.9M$39.0M
Operating income$11.7M-$13.7M-$26.4M-$12.3M
Net income$5.1M-$20.1M-$17.6M-$11.4M
EPS (diluted)0.27-1.10-1.03-0.64
Operating cash flow$18.7M$4.9M-$7.2M$10.7M
Cash$23.4M$13.4M$13.9M$18.2M
Long-term debt$21.4M$30.8M$34.2Mn/a
Buybacksn/an/a$7.5M$20.0M
SEC XBRL, fiscal years, as known on 2026-10-28

OPRX Stock Sonar score 5/7 axes

Find similar shapesCompare

OPRX ranks highest on growth (75th percentile) and financial health (73rd), and lowest on risk and compliance (25th), among Services peers.

ProfitHealthGrowthInstitutionsRisk
Profitability
53
Inputs
  • Return on equity+3.7% · 44 pct, sector of 207
  • Return on assets+2.8% · 59 pct, sector of 269
  • Return on invested capitaltax provision or pre-tax income not filed for the four quarters
  • Return on capital employed+7.2% · 55 pct, sector of 203
Financial health
73
Inputs
  • Debt to equity0.15x · 65 pct, sector of 228
  • Cash flow to debt0.97x · 82 pct, sector of 199
Growth
75
Inputs
  • Revenue growth, YoY+18.8% · 75 pct, sector of 341
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
38
Inputs
  • Funds adding, latest quarter54 · 38 pct, sector of 243
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
25
Inputs
  • Short interest, % of float+7.5% · 25 pct, sector of 384
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+18.1% · 25 pct, sector of 227
2 not measured: Insider conviction, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies